Browse
Submit Data
Databases
API
Help

Dataset Information

27 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

1?,15?-Dihy-droxy-16?,17-ep-oxy-pregn-4-ene-3,20-dione.

ABSTRACT: The title mol-ecule, C21H28O5, is composed of three six-membered rings (A/B/C) and a five-membered ring (D). Ring A adopts a 1?-sofa conformation, while rings B and C adopt chair conformations. Cyclo-pentane ring D adopts a 14?-envelope conformation. In the crystal, O-H?O hydrogen bonds lead to the formation of ribbons running along the a axis. The structure is further consolidated by C-H?O inter-actions, which link the molecules head-to-tail into ribbons along the a axis.

SUBMITTER: Shen YB

PROVIDER: S-EPMC3588417 | biostudies-literature | 2013 Mar

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

1β,15α-Dihy-droxy-16α,17-ep-oxy-pregn-4-ene-3,20-dione.

Shen Yan-Bing YB Wang Yi-Bo YB Luo Jian-Mei JM Wang Min M

Acta crystallographica. Section E, Structure reports online 20130228 Pt 3

The title mol-ecule, C21H28O5, is composed of three six-membered rings (A/B/C) and a five-membered ring (D). Ring A adopts a 1α-sofa conformation, while rings B and C adopt chair conformations. Cyclo-pentane ring D adopts a 14α-envelope conformation. In the crystal, O-H⋯O hydrogen bonds lead to the formation of ribbons running along the a axis. The structure is further consolidated by C-H⋯O inter-actions, which link the molecules head-to-tail into ribbons along the a axis. ...[more]

PMID: 23476615

Similar Datasets

11?,15?-Dihy-droxy-androst-4-ene-3,17-dione.

Project description:The title compound, C(19)H(26)O(4), was biotransformed from androstenedione. In the crystal, inter-molecular O-H?O hydrogen bonds link molecules into a corrugated sheet, which lies parallel to the ab plane. Ring A has a slightly distorted half-chair conformation, rings B and C adopt chair conformations, while the cyclo-pentane ring D adopts a 14?-envelope conformation.

| S-EPMC3201477 | biostudies-literature

17?-Acet-oxy-11?-hy-droxy-6?-methyl-pregn-4-ene-3,20-dione.

Project description:The title compound, C(24)H(34)O(5), a fungal-transformed metabolite of the injecta-ble contraceptive medroxyprogesterone acetate, consists of four fused rings (A, B, C and D; steroid labelling). Ring A exists in a half-chair conformation while trans-fused rings B and C adopt chair conformations. The five-membered ring D adopts an envelope conformation with the C atom bound to the methyl group at the flap. In the crystal, adjacent mol-ecules are linked by O-H?O and C-H?O hydrogen bonds, forming infinite chains along the a axis.

| S-EPMC3393278 | biostudies-other

6?,15?-Diacet-oxy-1?,7?,13?-trihydr-oxy-7?,20-ep-oxy-ent-kaur-16-ene.

Project description:The title compound, C(24)H(34)O(8), a natural ent-kaurane diterpenoid, is composed of four rings with the expected cis and trans junctions. The crystal structure is stabilized by inter-molecular O-H?O hydrogen bonds. In addition, an intra-molecular O-H?O hydrogen bond occurs.

| S-EPMC2979703 | biostudies-literature

1?,6?,7?,14?,15?-Penta-hydr-oxy-7?,20-ep-oxy-ent-kaur-16-ene.

Project description:The title compound, enmenol, C(20)H(30)O(6), a natural ent-kaurane diterpenoid, comprises five fused rings, four of which are six-membered. Cyclo-hexane ring A adopts a chair conformation, rings B and C adopt boat conformations, while ring D has an envelope conformation, and two intramolecular O-H?O interactions occur. In the crystal, inter-molecular O-H?O hydrogen bonds generate a two dimensional network.

| S-EPMC2980239 | biostudies-literature

4?-Hy-droxy-12,13-ep-oxy-trichothec-9-ene.

Project description:The asymmetric unit in the crystal of the title compound, C(15)H(22)O(3), contains two independent mol-ecules with similar structures. Each mol-ecule contains two six-membered rings and one five-membered ring. The five-membered ring displays an envelope conformation with the C atom linking the epoxy group as the flap, while the two six-membered rings show half-chair conformations. The two independent mol-ecules are linked by an O-H?O hydrogen bond. These dimers are further linked by O-H?O hydrogen bonds, forming supra-molecular chains running along the a axis.

| S-EPMC3344132 | biostudies-literature

21-(3-Carboxy-propano-yl)-11?,17-dihydroxy-pregn-4-ene-3,20-dione monohydrate.

Project description:In the title compound, C(25)H(34)O(8)·H(2)O, the two crylohexane rings adopt chair conformations. In the crystal, the organic mol-ecule and the water mol-ecule are linked by O-H?O hydrogen bonds, generating a three-dimensional network.

| S-EPMC2979527 | biostudies-literature

15?,20?-Dihydr-oxy-6?-meth-oxy-6,7-seco-6,20-ep-oxy-1,7-olide-ent-kaur-16-ene.

Project description:The title compound, C(21)H(30)O(6), a natural ent-kaurane diterpenoid, was obtained from the medicinal plant Isodon serra. The five rings in the mol-ecule exhibit the expected cis and trans junctions. The three six-membered rings adopt chair, twist-boat and boat conformations, while two five-membered rings adopt envelope conformations. There are two mol-ecules in the asymmetric unit, related by a non-crystallographic twofold screw axis; the main difference is in the different degrees of distortion of ring B. In the crystal, the mol-ecules are linked by inter-molecular O-H?O hydrogen bonds, forming chains along the b axis.

| S-EPMC2984011 | biostudies-other

21-Hy-droxy-pregna-1,4-diene-3,20-dione.

Project description:The title compound, C(21)H(28)O(3), is a fungal transformed metabolite of decoxycorticosterone acetate, consisting of four fused rings A, B, C and D. Ring A is nearly planar, with a maximum deviation of 0.010?(3)?Å from the least-squares plane, while the trans-fused rings B and C adopt chair conformations. The five-membered ring D is in an envelope conformation. The orientation of the side chain is stabilized by an intramolecular O-H?O hydrogen bond. In the crystal, adjecent mol-ecules are linked by C-H?O hydrogen bonds into extended zigzag chains along the a axis.

| S-EPMC3213563 | biostudies-literature

16?,17?-Ep-oxy-5?-hydr-oxy-6?-nitrooxy-20-oxopregnan-3?-yl acetate.

Project description:The title steroid, C(23)H(33)NO(8), is a pregnane derivative obtained regio-, stereo- and chemoselectively from the ring opening of the corresponding 5?,6?;16?,17?-diepoxide with bis-muth(III) nitrate. There are two symmetry-independent mol-ecules in the asymmetric unit that show no significant differences concerning bond lengths and angles. All rings are trans-fused. The conformations of the six-membered rings are close to chair forms, while the five-membered ring adopts an envelope conformation. The mol-ecules are held together by an extensive O-H?O hydrogen-bonding network of chains runnning along the a axis.

| S-EPMC2969566 | biostudies-literature

Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16?,17?-[(R)-(1'-?-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.

Project description:This first-in-human study was designed to evaluate the safety and dosimetry of the progesterone analog 21-(18)F-fluoro-16?,17?-[(R)-(1'-?-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione ((18)F-FFNP), as well the feasibility of imaging tumor progesterone receptors (PRs) by PET in breast cancer.Women with breast cancer underwent PET with (18)F-FFNP. Tumor (18)F-FFNP uptake was assessed semiquantitatively by determining maximum standardized uptake value and tumor-to-normal breast (T/N) activity ratio and by Logan graphical analysis. The PET results were correlated with estrogen receptor (ER) and PR status, assessed by in vitro assays of the tumor tissue. The biodistribution of (18)F-FFNP was measured in patients by whole-body PET, and human dosimetry was estimated.Twenty patients with 22 primary breast cancers (16 PR-positive [PR+] and 6 PR-negative [PR-]) were evaluated. Tumor maximum standardized uptake value was not significantly different in PR+ and PR- cancers (mean ± SD, 2.5 ± 0.9 vs. 2.0 ± 1.3, P = 0.386), but the T/N ratio was significantly greater in the PR+ cancers (2.6 ± 0.9 vs. 1.5 ± 0.3, P = 0.001). In addition, there was a significant correlation between distribution volume ratio and T/N ratio (r = 0.89; P = 0.001) but not between distribution volume ratio and either PR status or standardized uptake value, likely because of small sample size. On the basis of whole-body PET data in 12 patients, the gallbladder appeared to be the dose-limiting organ, with an average radiation dose of 0.113 mGy/MBq. The whole-body dose was 0.015 mGy/MBq, and the effective dose was 0.020 mSv/MBq. No adverse effects of (18)F-FFNP were encountered.(18)F-FFNP PET is a safe, noninvasive means for evaluating tumor PRs in vivo in patients with breast cancer. The relatively small absorbed doses to normal organs allow for the safe injection of up to 440 MBq of (18)F-FFNP.

| S-EPMC3595048 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data